
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20422934
[patent_doc_number] => 20250385019
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-18
[patent_title] => COPPER-64 COMPOSITIONS AND FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 19/242849
[patent_app_country] => US
[patent_app_date] => 2025-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19242849
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/242849 | COPPER-64 COMPOSITIONS AND FORMULATIONS | Jun 17, 2025 | Pending |
Array
(
[id] => 20196644
[patent_doc_number] => 20250273354
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-28
[patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64
[patent_app_type] => utility
[patent_app_number] => 19/195850
[patent_app_country] => US
[patent_app_date] => 2025-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19195850
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/195850 | PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 | Apr 30, 2025 | Pending |
Array
(
[id] => 20153228
[patent_doc_number] => 20250253066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-07
[patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64
[patent_app_type] => utility
[patent_app_number] => 19/184830
[patent_app_country] => US
[patent_app_date] => 2025-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19184830
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/184830 | Purification process for the preparation of non-carrier added copper-64 | Apr 20, 2025 | Issued |
Array
(
[id] => 20163924
[patent_doc_number] => 20250255970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-14
[patent_title] => BIOORTHOGONAL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 19/180813
[patent_app_country] => US
[patent_app_date] => 2025-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32609
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19180813
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/180813 | BIOORTHOGONAL COMPOSITIONS | Apr 15, 2025 | Pending |
| 19/030236 | COPPER-64 COMPOSITIONS AND FORMULATIONS | Jan 16, 2025 | Pending |
Array
(
[id] => 19889173
[patent_doc_number] => 20250114485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-10
[patent_title] => GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING
[patent_app_type] => utility
[patent_app_number] => 18/983625
[patent_app_country] => US
[patent_app_date] => 2024-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24828
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18983625
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/983625 | Gadolinium chelate compounds for use in magnetic resonance imaging | Dec 16, 2024 | Issued |
Array
(
[id] => 20006011
[patent_doc_number] => 20250144233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-08
[patent_title] => NOVEL GENE DELIVERY AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/932511
[patent_app_country] => US
[patent_app_date] => 2024-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18932511
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/932511 | Gene delivery agents | Oct 29, 2024 | Issued |
Array
(
[id] => 20048410
[patent_doc_number] => 20250186632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => FIBROBLAST ACTIVATION PROTEIN TARGETING PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 18/930419
[patent_app_country] => US
[patent_app_date] => 2024-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7425
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18930419
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/930419 | Fibroblast activation protein targeting peptides | Oct 28, 2024 | Issued |
Array
(
[id] => 19528142
[patent_doc_number] => 20240352044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 18/757905
[patent_app_country] => US
[patent_app_date] => 2024-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10594
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 340
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18757905
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/757905 | METAL ALKOXIDE COMPOUND, THIN FILM FORMING RAW MATERIAL, AND THIN FILM PRODUCTION METHOD | Jun 27, 2024 | Pending |
Array
(
[id] => 19943513
[patent_doc_number] => 12315649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-27
[patent_title] => Purification process for the preparation of non-carrier added copper-64
[patent_app_type] => utility
[patent_app_number] => 18/745896
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16894
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745896 | Purification process for the preparation of non-carrier added copper-64 | Jun 16, 2024 | Issued |
Array
(
[id] => 19912408
[patent_doc_number] => 12288627
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-29
[patent_title] => Copper-64 compositions and formulations
[patent_app_type] => utility
[patent_app_number] => 18/745906
[patent_app_country] => US
[patent_app_date] => 2024-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 31291
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18745906
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/745906 | Copper-64 compositions and formulations | Jun 16, 2024 | Issued |
Array
(
[id] => 19483847
[patent_doc_number] => 20240331889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64
[patent_app_type] => utility
[patent_app_number] => 18/733537
[patent_app_country] => US
[patent_app_date] => 2024-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18733537
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/733537 | PURIFICATION PROCESS FOR THE PREPARATION OF NON-CARRIER ADDED COPPER-64 | Jun 3, 2024 | Pending |
Array
(
[id] => 19402308
[patent_doc_number] => 20240285819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/655741
[patent_app_country] => US
[patent_app_date] => 2024-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18655741
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/655741 | COMPOSITION OF RADIOACTIVE AND NON-RADIOACTIVE MICROPARTICLES | May 5, 2024 | Pending |
Array
(
[id] => 19799071
[patent_doc_number] => 20250064996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/649569
[patent_app_country] => US
[patent_app_date] => 2024-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18649569
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/649569 | STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF | Apr 28, 2024 | Pending |
Array
(
[id] => 19387576
[patent_doc_number] => 20240277446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => MULTI-MODE IMAGING MARKERS
[patent_app_type] => utility
[patent_app_number] => 18/646526
[patent_app_country] => US
[patent_app_date] => 2024-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18646526
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/646526 | Multi-mode imaging markers | Apr 24, 2024 | Issued |
Array
(
[id] => 19585074
[patent_doc_number] => 20240382631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/628570
[patent_app_country] => US
[patent_app_date] => 2024-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8878
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18628570
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/628570 | USE OF LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA), AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER | Apr 4, 2024 | Pending |
Array
(
[id] => 19462557
[patent_doc_number] => 20240316226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/614094
[patent_app_country] => US
[patent_app_date] => 2024-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18614094
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/614094 | RADIOPHARMACEUTICAL CONJUGATE COMPOUND FOR DIAGNOSIS AND/OR THERAPEUTIC USES THEREOF | Mar 21, 2024 | Issued |
Array
(
[id] => 19563571
[patent_doc_number] => 12138322
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Method of preventing the development of melanoma
[patent_app_type] => utility
[patent_app_number] => 18/610095
[patent_app_country] => US
[patent_app_date] => 2024-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 8217
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18610095
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/610095 | Method of preventing the development of melanoma | Mar 18, 2024 | Issued |
Array
(
[id] => 19403535
[patent_doc_number] => 20240287046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOUNDS AND RADIOLIGANDS FOR TARGETING NEUROTENSIN RECEPTOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/604397
[patent_app_country] => US
[patent_app_date] => 2024-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18604397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/604397 | Compounds and radioligands for targeting neurotensin receptor and uses thereof | Mar 12, 2024 | Issued |
Array
(
[id] => 19526778
[patent_doc_number] => 20240350680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/440783
[patent_app_country] => US
[patent_app_date] => 2024-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18440783
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/440783 | LABELED INHIBITORS OF PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) AS AGENTS FOR THE TREATMENT OF PROSTATE CANCER | Feb 12, 2024 | Pending |